The vicious cycle between ferritinophagy and ROS production triggered EMT inhibition of gastric cancer cells was through p53/AKT/mTor pathway

Chemico-biological Interactions
Zhongjie XuCuiping Li

Abstract

Cancer metastasis and resistance for chemotherapeutic agent correlate with epithelial-mesenchymal transition (EMT), while ROS production also involves in the EMT process, However, how autophagy mediated ROS production affects EMT remains unclear. Previous study showed that DpdtC (2,2'-di-pyridylketone hydrazone dithiocarbamate) could induce ferritinophagy in HepG2 cell. To insight into more details that how ferritinophagy affects cellular feature, the SGC-7901and BGC-823 gastric cancer cell lines were used. Interestingly DpdtC treatment resulted in EMT inhibition and was ROS dependent. Similar situation occurred in TGF-β1 induced EMT model, supporting that DpdtC was able to inhibit EMT. Next the ability of DpdtC in ferritinophagy induction was further evaluated. As expected, DpdtC induced ferritinophagy in the absence and presence of TGF-β1. The correlation analysis revealed that an enhanced ferritinophagic flux contributed to the EMT inhibition. In addition, ferritinophagy triggers Fenton reaction, resulting in ROS production which give rise of p53 response, thus the role of p53 was further investigated. DpdtC treatment resulted in upregulation of p53, but, the addition of p53 inhibitor, PFT-α could significantly neutralize th...Continue Reading

References

Mar 1, 1989·Archives of Biochemistry and Biophysics·M C LinderG M Nagel
Dec 1, 2000·Nature·B VogelsteinA J Levine
Jun 2, 2005·Proceedings of the National Academy of Sciences of the United States of America·Zhaohui FengShengkan Jin
Apr 15, 2008·Trends in Molecular Medicine·Nancy Gavert, Avri Ben-Ze'ev
Apr 22, 2008·Free Radical Biology & Medicine·Yvonne M W Janssen-HeiningerAlbert van der Vliet
Dec 9, 2008·The Biochemical Journal·Michael P Murphy
Jul 9, 2009·Cancer Research·Thiruvengadam ArumugamWoonyoung Choi
Mar 27, 2010·Current Pharmaceutical Design·Michael FrezzaQ Ping Dou
Sep 21, 2011·Antioxidants & Redox Signaling·Elisa GiannoniPaola Chiarugi
Feb 11, 2012·Clinical & Experimental Metastasis·Daniela Spano, Massimo Zollo
Mar 1, 2012·International Review of Cell and Molecular Biology·KangAe Lee, Celeste M Nelson
Aug 23, 2012·Antioxidants & Redox Signaling·Alexei Terman, Tino Kurz
Aug 31, 2012·Mini Reviews in Medicinal Chemistry·Daniela BuacQ Ping Dou
Jan 23, 2013·Breast Cancer Research and Treatment·Antoinette HollestelleJohn W M Martens
Feb 22, 2014·Nature Reviews. Molecular Cell Biology·Samy LamouilleRik Derynck
Jun 10, 2014·Molecular Cell·Roberto BellelliFrancesca Carlomagno
May 30, 2015·Expert Opinion on Emerging Drugs·Bruno VincenziGiuseppe Tonini
Sep 19, 2015·Computational and Structural Biotechnology Journal·Xiandong LinBin Zhang
Mar 25, 2016·Nature Reviews. Cancer·Giovanni StracquadanioGareth L Bond
May 6, 2016·Annual Review of Biochemistry·Andreas C Joerger, Alan R Fersht
Apr 14, 2017·Journal of Inflammation Research·Apostolos SioutasHans Lennart Persson
Aug 5, 2017·Journal of Experimental & Clinical Cancer Research : CR·I AversaF Costanzo
Mar 2, 2018·Antioxidants & Redox Signaling·Paul J M WijnkerJolanda van der Velden
Jun 3, 2018·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·Thorsten Stiewe, Tali E Haran
Nov 23, 2018·The Journal of Steroid Biochemistry and Molecular Biology·Chiara RiccaFrancesca Silvagno
Mar 28, 2019·Frontiers in Endocrinology·Yi LiXue-Qun Chen
Aug 30, 2019·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Jee-Yeon LeeKwon-Soo Ha
Nov 5, 2019·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Jong Hyun LeeKwang Seok Ahn
Nov 22, 2019·Cellular and Molecular Life Sciences : CMLS·Jean-Pierre MazatStéphane Ransac
Dec 11, 2019·British Journal of Cancer·Vittoria RaimondiVincenzo Ciminale
Apr 8, 2020·Oxidative Medicine and Cellular Longevity·Jiankang FengChangzheng Li

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autophagy & Model Organisms

Autophagy is a cellular process that allows degradation by the lysosome of cytoplasmic components such as proteins or organelles. Here is the latest research on autophagy & model organisms